Nikolai Alexandrovich Podoltsev

机构：Yale Cancer Center, Yale University, University of New Haven · ORCID：0000-0002-3657-778X

发表论文 305 篇 · 总被引 6369 次 · h-index 37

代表论文

• Tuscany Study demonstrates safety and efficacy of tuspetinib plus standard of care venetoclax and azacitidine in patients with newly diagnosed AML ineligible for induction chemotherapy (2025 · Blood · 被引 2)
• Genomic determinants of treatment outcome and identification of a new genomic subset of adult acute lymphoblastic leukemia from the ECOG-ACRIN E1910 randomized phase III trial (2025 · Blood · 被引 2)
• Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET) (2026 · The Lancet Regional Health - Americas · 被引 1)
• Acute myeloid leukemia after myeloproliferative neoplasms: Real‐world outcomes in the new treatment era in the United States (2026 · Cancer · 被引 1)
• Acute myeloid leukemia (AML) after myeloproliferative neoplasm (MPN): Real-world outcomes in the new AML treatment era (2025 · Blood · 被引 1)
• Selinexor plus ruxolitinib in JAK inhibitor–naïve myelofibrosis: Phase 3 SENTRY trial. (2026 · Journal of Clinical Oncology)